Cargando…

Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient

Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Eswaran, Sudhagar, Balan, Sarath Kumar, Saravanam, Prasanna Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265298/
https://www.ncbi.nlm.nih.gov/pubmed/34258246
http://dx.doi.org/10.1007/s12070-021-02689-4
_version_ 1783719742404558848
author Eswaran, Sudhagar
Balan, Sarath Kumar
Saravanam, Prasanna Kumar
author_facet Eswaran, Sudhagar
Balan, Sarath Kumar
Saravanam, Prasanna Kumar
author_sort Eswaran, Sudhagar
collection PubMed
description Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we report a case of 31 year old male with covid 19 infection who had new onset Diabetes Mellitus, developed severe acute fulminant Mucormycosis during the treatment for covid 19 infection. He presented with severe headache, nasal obstruction and discharge, bilateral ophthalmoplegia and blindness with Cavernous Sinus Thrombosis. Patient underwent aggressive surgical debridement with frontal craniectomy, maxillectomy and right orbital evisceration and left endoscopic orbital decompression and judicious efforts to revert back the immunocompromised status with high dose of Liposomal amphotericin. Post operatively patient developed right temporal lobe abscess which was drained through Endonasal Endoscopic Trans Cavernous drainage of Temporal Lobe Abscess. Patient is in 2 months follow up, with bilateral blindness and tolerating oral feeds with improved left eye ophthalmoplegia. It is imperative to note that the rising trend of mucormycosis is there in Covid 19 infections and it should be dealt with high index of suspicion in high risk patients and early aggressive treatment can save the patient as the survival rate is not high in such infections.
format Online
Article
Text
id pubmed-8265298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-82652982021-07-09 Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient Eswaran, Sudhagar Balan, Sarath Kumar Saravanam, Prasanna Kumar Indian J Otolaryngol Head Neck Surg Clinical Report Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we report a case of 31 year old male with covid 19 infection who had new onset Diabetes Mellitus, developed severe acute fulminant Mucormycosis during the treatment for covid 19 infection. He presented with severe headache, nasal obstruction and discharge, bilateral ophthalmoplegia and blindness with Cavernous Sinus Thrombosis. Patient underwent aggressive surgical debridement with frontal craniectomy, maxillectomy and right orbital evisceration and left endoscopic orbital decompression and judicious efforts to revert back the immunocompromised status with high dose of Liposomal amphotericin. Post operatively patient developed right temporal lobe abscess which was drained through Endonasal Endoscopic Trans Cavernous drainage of Temporal Lobe Abscess. Patient is in 2 months follow up, with bilateral blindness and tolerating oral feeds with improved left eye ophthalmoplegia. It is imperative to note that the rising trend of mucormycosis is there in Covid 19 infections and it should be dealt with high index of suspicion in high risk patients and early aggressive treatment can save the patient as the survival rate is not high in such infections. Springer India 2021-07-08 2022-10 /pmc/articles/PMC8265298/ /pubmed/34258246 http://dx.doi.org/10.1007/s12070-021-02689-4 Text en © Association of Otolaryngologists of India 2021
spellingShingle Clinical Report
Eswaran, Sudhagar
Balan, Sarath Kumar
Saravanam, Prasanna Kumar
Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title_full Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title_fullStr Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title_full_unstemmed Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title_short Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient
title_sort acute fulminant mucormycosis triggered by covid 19 infection in a young patient
topic Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265298/
https://www.ncbi.nlm.nih.gov/pubmed/34258246
http://dx.doi.org/10.1007/s12070-021-02689-4
work_keys_str_mv AT eswaransudhagar acutefulminantmucormycosistriggeredbycovid19infectioninayoungpatient
AT balansarathkumar acutefulminantmucormycosistriggeredbycovid19infectioninayoungpatient
AT saravanamprasannakumar acutefulminantmucormycosistriggeredbycovid19infectioninayoungpatient